- In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment
-
Hirschfield H, Bian CB, Higashi T, Nakagawa S, Zeleke TZ, Nair VD, Fuchs BC, Hoshida Y
- KMID: 2438349
- Exp Mol Med.
- 2018 Jan;50(1):e419.
- doi: 10.1038/emm.2017.164
Tractable experimental model that accounts for inter-tumor molecular heterogeneity is a key element of anti-cancer drug development. Hepatocellular carcinoma is known to exhibit highly heterogeneous molecular aberrations across the tumors,... -
- CITED
-
- Close
- SHARE
-
- Close
